Biovision, Lyon, France (ots/PRNewswire) – Institut Pasteur of Shanghai announces today the creation of its global biotech accelerator company Advance BioChina. Advance BioChina is an R&D-focused for-profit organization that positions itself as the gateway to China for global biotech companies. Advance BioChina co-invests with global biotech companies into Shanghai-based Joint Ventures. Advance BioChina will incubate [...]
Tag Archive > Biotech Companies
EANS-Adhoc: – Marseille-Kliniken AG appoints new member to Management Board
——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– 11.06.2010 Berlin, 11 June 2010. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has appointed Dr. Thomas Klaue (52) to the Management [...]
Stable F&E Budgets help Biotech Suppliers Defy the Crisis
(pressebox) Berlin, 16.06.2009, Several American pharmaceutical giants such as Pfizer, Johnson & Johnson or Merck & Co are currently fighting losses in sales and a lack of upcoming products. In Europe, Sanofi-Aventis and GlaxoSmithKline are affected. However, not all pharmaceutical companies are suffering from the crisis. According to the assessment of many analysts, Roche, Novartis [...]
Scienion receives ISO 9001:2008 certification
(pressebox) Dortmund, Germany, 18.02.2009, Scienion AG, Dortmund, today announced the DIN EN ISO 9001:2008 certification for the development, manufacture and sales of dispensing systems and microarrays. Scienion is one of the first biotech companies that have been certified according to the latest revision of the world’s most widely used standard for quality management systems. "The [...]
Fragment Based Screening Service at CRELUX and ZoBio
Caption: Co-crystal structures of 3 fragments bound to Pim1 kinase. (pressebox) Munich/Leiden, 24.11.2008 – CRELUX and ZoBio announced today that they have successfully executed their first fragment based screening projects from a jointly established platform. One of the first targets, which also will be made accessible to customers, was Pim1, a kinase that has been [...]
